Internship
Posted on 9/6/2024
Gene editing technology for genetic diseases
No H1B Sponsorship
Belmont, MA, USA
Candidates must be from the local Boston/Cambridge area.
Prime Medicine focuses on gene editing, specifically using a technology called Prime Editing to make precise changes to DNA. This technology can identify and fix faulty DNA segments, which helps restore normal genetic function. The company aims to cure, halt, or prevent genetic diseases, providing long-term benefits to patients. Unlike many competitors, Prime Medicine collaborates with research institutions and pharmaceutical companies to advance its technology and bring it to market, generating revenue through licensing and partnerships. The leadership team has significant experience in developing innovative medicines, highlighting the company's commitment to enhancing its capabilities and operations.
Company Stage
IPO
Total Funding
$306.4M
Headquarters
Cambridge, Massachusetts
Founded
2019
Help us improve and share your feedback! Did you find this helpful?